Last reviewed · How we verify
NCT03922906
Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
NA trial testing Pure-Vu System in CRC in 3 participants. Terminated before completion.
25 February 2020
Quick facts
| Lead sponsor | Motus GI Medical Technologies Ltd |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 3 |
| Start date | 21 January 2020 |
| Primary completion | 25 February 2020 |
| Estimated completion | 2 February 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Pure-Vu System
Conditions studied
- CRC — all drugs for CRC →
Sponsor
Motus GI Medical Technologies Ltd
Who can join
Adults 22 to 75, any sex, with CRC. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aim to evaluate the performance of Pure-Vu System in cleansing patients' colon with history of inadequate bowel preparation who are indicated for a colonoscopy procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03922906
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pure-Vu System
Trials testing the same drug.
- NCT04700410 — Bowel Cleansing Performance of the Pure-Vu System in Patients With a History of Poor Bowel Preparation · NA · completed
- NCT04285008 — Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who · NA · withdrawn
- NCT03503162 — Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System · NA · completed
- NCT03493009 — Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System · NA · withdrawn
Other recruiting trials for CRC
Currently open trials in the same condition.
- NCT06682793 — A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumor · Phase 1, PHASE2 · recruiting
- NCT07204574 — The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Effic · Phase 1, PHASE2 · recruiting
- NCT06728072 — Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer · Phase 2 · recruiting
- NCT06445062 — Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · Phase 1, PHASE2 · recruiting
- NCT05382377 — NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors · EARLY_PHASE1 · recruiting
Other Motus GI Medical Technologies Ltd trials
Trials by the same sponsor.
- NCT05585879 — Demonstrating Effective Salvage of Inadequate Colonoscopies · NA · terminated
- NCT04285008 — Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who · NA · withdrawn
- NCT03503162 — Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System · NA · completed
- NCT03493009 — Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System · NA · withdrawn
- NCT03026075 — Evaluation of the Performance of the Motus Cleansing System (MCS) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03922906 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Motus GI Medical Technologies Ltd
- Last refreshed: 25 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922906.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing